US Core PCE Inflation Prints at 3.0% as Merck Drug Succeeds in Phase 2b
Newsquawk ·
The US annualized Core PCE Price Index for August rose 3.0%, coming in below the consensus forecast of 3.3% while matching the previous reading of 3.0%. As the Federal Reserve's favored inflation metric, this downside surprise relative to expectations impacts front-end yield curves and the US dollar. In corporate developments, Merck ticker MRK announced that tulisokibart achieved its primary and key secondary goals in a Phase 2b trial involving patients suffering from moderate to severe hidradenitis suppurativa. Additionally, the US ADP National Employment Report for September showed job growth of 90,000, surpassing the anticipated 70,000 and accelerating from the downwardly revised prior figure of 38,000. Analysts emphasize that while the inflation data points toward cooling price pressures, sustainable policy adjustments by the central bank will likely require a broader sequence of confirming data rather than relying on a single monthly release within their ongoing data-dependent framework.
AI 시장 분석
The U.S. August core PCE price index rose 3.0% year-over-year, coming in below the market expectation of 3.3% and signaling easing inflation pressures. Meanwhile, the ADP employment report showed an increase of 90,000 jobs, beating expectations, and positive clinical trial results for Merck's new drug were also announced. These indicators stimulated expectations for Federal Reserve rate cuts, acting as immediate downward pressure on short-term interest rates and the U.S. dollar.
상승 영향
- Growth Stocks — The core PCE inflation rate recorded 3.0%, below the expectation (3.3%), raising expectations for the end of Fed tightening and rate cuts, thereby easing valuation burdens.
- Biotech — Merck's (MRK) tulisokibart met primary and secondary endpoints in Phase 2b trials, improving investment sentiment in the related pharmaceutical and biotech sector due to expectations for new drug development.
- Bonds — As signs of a slowdown in inflationary pressure became clear, Treasury yields faced downward pressure, creating a favorable environment for rising bond prices (falling yields).
하락 영향
- USD — Lower-than-expected inflation indicators raised the possibility of aggressive Fed rate cuts, acting as downward pressure on the value of the dollar.
DYAX 전담 분석
The core PCE coming in below expectations increases the likelihood of a shift in the Fed's monetary policy, creating a favorable environment for growth stocks and the bond market. However, given the Fed's stance of relying on single data points, continued confirmation of price stability is necessary, and combined with strong employment indicators, market volatility could expand.
The bullish scenario is the acceleration of rate cuts due to confirmation of further inflation slowdown, while the bearish scenario is the resurgence of wage-driven inflation from employment. Key indicators to monitor going forward include speeches by Fed officials and the monthly inflation growth rate.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 66% · Bearish (Short) 34%
383 participants
Related News
- EIA Inventories Expected: Crude Up 500K, Gasoline Down 1M
- Mexico Grows Optimistic Over Potential US Steel and Auto Tariff Cuts
- India Greenlights Massive $19.42 Billion Renewable Energy Initiative
- US Treasury Block Trades and September Chicago PMI Highlights
- Chicago PMI Surges in September Alongside Regional Gaming Revenue and NATO Security Updates
- NATO Chief Rutte Sees No Immediate Danger, While Regional Data and Reports Cross Wires
